Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
Juhyun Song, Jong‐Pil Kim
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, et al.
JAMA Neurology (2019) Vol. 76, Iss. 4, pp. 420-420
Open Access | Times Cited: 208
Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?
Vignayanandam Ravindernath Muddapu, S. Akila Parvathy Dharshini, V. Srinivasa Chakravarthy, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 207
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Swati Agarwal, Anuradha Yadav, Rajnish Kumar Chaturvedi
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1166-1177
Closed Access | Times Cited: 157
Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain
Małgorzata Kujawska, Michaël Jourdes, Monika Kurpik, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 202-202
Open Access | Times Cited: 133
Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
Aleksandra Gąsecka, Dominika Siwik, Magdalena Gajewska, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2807-2807
Open Access | Times Cited: 87
The neuroprotective potential of carotenoids in vitro and in vivo
Janani Manochkumar, C. George Priya Doss, Hesham R. El‐Seedi, et al.
Phytomedicine (2021) Vol. 91, pp. 153676-153676
Closed Access | Times Cited: 83
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Yohan Santin, Jessica Resta, Angelo Parini, et al.
Ageing Research Reviews (2021) Vol. 66, pp. 101256-101256
Open Access | Times Cited: 73
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
Marco Hadisurya, Li Li, Kananart Kuwaranancharoen, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 27
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Jasmina Isaković, Klara Šerer, Barbara Barišić, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 25
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
Shuchun Chen, Seong‐Jin Yu, Yazhou Li, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Luigi Ferini‐Strambi, Giulia Carli, Francesca Casoni, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 49
Diabetes Mellitus and Parkinson’s Disease: A Systematic Review and Meta-Analyses
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1585-1596
Closed Access | Times Cited: 40
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 5
Induced Pluripotent Stem Cells
Chia-Yu Chang, Hsiao-Chien Ting, Ching-Ann Liu, et al.
Cell Transplantation (2018) Vol. 27, Iss. 11, pp. 1588-1602
Open Access | Times Cited: 31
Insulin deficiency: A possible link between obesity and cognitive function
Ghazaleh Nameni, Mahdieh Abbasalizad Farhangi, Ghazaleh Hajiluian, et al.
International Journal of Developmental Neuroscience (2017) Vol. 59, Iss. 1, pp. 15-20
Closed Access | Times Cited: 30
High fat diet-induced obesity causes a reduction in brain tyrosine hydroxylase levels and non-motor features in rats through metabolic dysfunction, neuroinflammation and oxidative stress
Aline Bittencourt, Pedro Ozorio Brum, Camila Tiefensee Ribeiro, et al.
Nutritional Neuroscience (2020) Vol. 25, Iss. 5, pp. 1026-1040
Closed Access | Times Cited: 24
Neurotoxic Effect of Fipronil in Male Wistar Rats: Ameliorative Effect of L-Arginine and L-Carnitine
Yasmina K. Mahmoud, Ahmed Ali, Heba M. A. Abdelrazek, et al.
Biology (2021) Vol. 10, Iss. 7, pp. 682-682
Open Access | Times Cited: 18
l -Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson’s disease
Khadga Raj, Ghanshyam Das Gupta, Shamsher Singh
Drug and Chemical Toxicology (2021) Vol. 45, Iss. 5, pp. 2097-2108
Closed Access | Times Cited: 17
Frailty and Parkinson’s disease: the role of diabetes mellitus
Klara Komici, Antonella Pansini, Leonardo Bencivenga, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
A High-fat Diet Induces a Loss of Midbrain Dopaminergic Neuronal Function That Underlies Motor Abnormalities
Yunseon Jang, Min Joung Lee, Jeongsu Han, et al.
Experimental Neurobiology (2017) Vol. 26, Iss. 2, pp. 104-112
Open Access | Times Cited: 20
Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson’s disease
Michael Sloth Trabjerg, Dennis Christian Andersen, Pam Huntjens, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson’s Model
Xiufeng Wang, Heng Zhai, Fang Wang
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 4825-4833
Closed Access | Times Cited: 17
Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study
Hsiu‐Li Lin, Hsiu‐Chen Lin, Yuan-Fu Tseng, et al.
European Journal of Clinical Pharmacology (2016) Vol. 73, Iss. 3, pp. 365-371
Closed Access | Times Cited: 15
CE‐MS with electrokinetic supercharging and application to determination of neurotransmitters
Shane S. Wells, Mohamed Dawod, Robert T. Kennedy
Electrophoresis (2019) Vol. 40, Iss. 22, pp. 2946-2953
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top